Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to demonstrate that a fixed dose combination of
telmisartan 80 mg plus hydrochlorothiazide 25 mg (T80/H25) is superior in reducing blood
pressure after eight weeks compared with a fixed dose combination of telmisartan 80 mg plus
hydrochlorothiazide 12.5 mg (T80/H12.5) in patients who fail to respond to six weeks
treatment with T80/H12.5.